Works about NON-small-cell lung carcinoma
Results: 5000
LncRNA HCG11 enhances the chemosensitivity of non-small cell lung cancer cells to Gemcitabine via miR-17-5p/p21 axis.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 1/2, p. 81, doi. 10.1080/14737140.2024.2305352
- By:
- Publication type:
- Article
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications.
- Published in:
- Expert Review of Clinical Immunology, 2024, v. 20, n. 8, p. 959, doi. 10.1080/1744666X.2024.2372327
- By:
- Publication type:
- Article
Safety of PD-L1 inhibitors versus PD-1 inhibitors in the treatment of lung cancer: a systematic review and network meta-analysis.
- Published in:
- Expert Review of Anticancer Therapy, 2025, v. 25, n. 3, p. 259, doi. 10.1080/14737140.2025.2465901
- By:
- Publication type:
- Article
The efficacy of Veliparib in combination with chemotherapy in the treatment of lung cancer: systematic review and meta-analysis.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 12, p. 1237, doi. 10.1080/14737140.2024.2417770
- By:
- Publication type:
- Article
First-in-human clinical trial results with ABBV-184, a first-in-class T-cell receptor/anti-CD3 bispecific protein, in adults with previously treated AML or NSCLC.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 9, p. 893, doi. 10.1080/14737140.2024.2373888
- By:
- Publication type:
- Article
First-line concomitant EGFR-TKI + chemotherapy versus EGFR-TKI alone for advanced EGFR-mutated NSCLC: a meta-analysis of randomized phase III trials.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 8, p. 775, doi. 10.1080/14737140.2024.2362889
- By:
- Publication type:
- Article
Navigating resistance to ALK inhibitors in the lorlatinib era: a comprehensive perspective on NSCLC.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 6, p. 347, doi. 10.1080/14737140.2024.2344648
- By:
- Publication type:
- Article
Design, synthesis, and biological evaluation of evodiamine-indolequinone hybrids as novel NQO1 agonists against non-small cell lung cancer.
- Published in:
- Arabian Journal of Chemistry, 2025, v. 18, n. 1, p. N.PAG, doi. 10.1016/j.arabjc.2024.106075
- By:
- Publication type:
- Article
Tanshinone IIA affects the proliferation of A549/Tax by affecting the expression of MMP7 through the PI3K-AKT-mTOR signaling pathway.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02152-8
- By:
- Publication type:
- Article
A novel PAK1/TCF1 regulatory axis promotes non-small cell lung cancer progression.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02110-4
- By:
- Publication type:
- Article
Comparative Effectiveness of First‐Line Pembrolizumab vs. Chemotherapy in aNSCLC: A Norwegian Population‐Based Cohort Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1123, doi. 10.1002/cpt.3591
- By:
- Publication type:
- Article
Orthoallosteric EGFR‐TKIs: A New Paradigm in NSCLC Treatment Strategy Targeting the C797S Mutation.
- Published in:
- Drug Development Research, 2025, v. 86, n. 1, p. 1, doi. 10.1002/ddr.70036
- By:
- Publication type:
- Article
3,3′-diindolylmethane induces ferroptosis and inhibits proliferation in non-small-cell lung cancer through the AHR/NRF2/GPX4 axis.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02096-z
- By:
- Publication type:
- Article
Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8<sup>+</sup> T cells as a predictor of clinical benefit.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02060-x
- By:
- Publication type:
- Article
Patient-reported outcomes in non-small cell lung cancer: psychometric evaluation of the PROMIS PF-SF 8c and NSCLC-SAQ in two phase 3 clinical trials.
- Published in:
- Quality of Life Research, 2025, v. 34, n. 3, p. 751, doi. 10.1007/s11136-024-03846-2
- By:
- Publication type:
- Article
NLRP4 unlocks an NK/macrophages-centered ecosystem to suppress non-small cell lung cancer.
- Published in:
- Biomarker Research, 2025, v. 13, n. 1, p. 1, doi. 10.1186/s40364-025-00756-4
- By:
- Publication type:
- Article
A Drug–Drug Interaction Study of Mobocertinib and Midazolam, a Cytochrome P450 3A Substrate, in Patients With Advanced Non–Small Cell Lung Cancer.
- Published in:
- Clinical Pharmacology in Drug Development, 2025, v. 14, n. 3, p. 252, doi. 10.1002/cpdd.1500
- By:
- Publication type:
- Article
The role of PD-L1 in EGFR-mutant non-small cell lung cancer.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02089-y
- By:
- Publication type:
- Article
Evaluating Different Anti-PD-1/PD-L1 Immunotherapies for Advanced Non-Small-Cell Lung Cancer.
- Published in:
- International Journal of High School Research, 2025, v. 7, n. 2, p. 78, doi. 10.36838/v7i2.11
- By:
- Publication type:
- Article
PD-1/L1 immune checkpoint inhibitors for KRAS-mutant non-small cell lung cancer: a multicenter retrospective real-world study.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13868-9
- By:
- Publication type:
- Article
Deep learning radiomics for the prediction of epidermal growth factor receptor mutation status based on MRI in brain metastasis from lung adenocarcinoma patients.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13823-8
- By:
- Publication type:
- Article
Validation for revision of the stage IIIA(T1N2) in the forthcoming ninth edition of the TNM classification for lung cancer.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-024-13364-6
- By:
- Publication type:
- Article
Corrigendum: Exploring the impact of HDL and LMNA gene expression on immunotherapy outcomes in NSCLC: a comprehensive analysis using clinical & gene data.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Ensartinib as a neoadjuvant therapy for stage IIIA non-small cell lung cancer patients with EML4-ALK fusion: a case report and literature review.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1474997
- By:
- Publication type:
- Article
Case Report: Grade 4 pneumonitis occurred after thoracic radiotherapy and dacomitinib in a patient with lung adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1436134
- By:
- Publication type:
- Article
Exploring the impact of HDL and LMNA gene expression on immunotherapy outcomes in NSCLC: a comprehensive analysis using clinical & gene data.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2024.1448966
- By:
- Publication type:
- Article
Severe thyroiditis induced by sintilimab monotherapy in a patient with non-small cell lung cancer: a case report and literature review.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1548452
- By:
- Publication type:
- Article
Adagrasib in KRYSTAL-12 has Not Broken the KRAS G12C Enigma Code of the Unspoken 6-Month PFS Barrier in NSCLC.
- Published in:
- Lung Cancer: Targets & Therapy, 2024, v. 15, p. 169, doi. 10.2147/LCTT.S492126
- By:
- Publication type:
- Article
Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer.
- Published in:
- ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 55, doi. 10.2147/CEOR.S501532
- By:
- Publication type:
- Article
Targeting NAD + biosynthesis suppresses TGF-β1/Smads/RAB26 axis and potentiates cisplatin cytotoxicity in non-small cell lung cancer brain metastasis.
- Published in:
- Acta Neuropathologica Communications, 2025, v. 13, n. 1, p. 1, doi. 10.1186/s40478-025-01967-4
- By:
- Publication type:
- Article
Glycyrrhizin enhances the antitumor activity of cisplatin in non‑small cell lung cancer cells by influencing DNA damage and apoptosis.
- Published in:
- Oncology Letters, 2025, v. 29, n. 4, p. N.PAG, doi. 10.3892/ol.2025.14954
- By:
- Publication type:
- Article
Clinical outcome analysis of different first‑ and second‑generation EGFR‑tyrosine kinase inhibitors in untreated patients with EGFR‑mutated non‑small cell lung cancer with baseline brain metastasis.
- Published in:
- Oncology Letters, 2025, v. 29, n. 4, p. N.PAG, doi. 10.3892/ol.2025.14947
- By:
- Publication type:
- Article
Efficacy of liquid biopsy for genetic mutations determination in non-small cell lung cancer: a systematic review on literatures.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13786-w
- By:
- Publication type:
- Article
Prognostic factors and the impact of adjuvant chemotherapy on recurrence and survival in stage I non-small cell lung cancer: A real-world study.
- Published in:
- European Research Journal, 2025, v. 11, n. 2, p. 351, doi. 10.18621/eurj.1633305
- By:
- Publication type:
- Article
Safety Diagnostic Tool for Non-Small Cell Lung Cancer (NSCLC) Lyophilized Serum.
- Published in:
- Clinical Cancer Investigation Journal, 2024, v. 13, n. 4, p. 15, doi. 10.51847/qIelHBRpUP
- By:
- Publication type:
- Article
Gut microbial predictors of first-line immunotherapy efficacy in advanced NSCLC patients.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-89406-1
- By:
- Publication type:
- Article
Cardiovascular toxicity induced by immunotherapy in non-small cell lung cancer: a systematic review and meta-analysis of observational studies.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1528950
- By:
- Publication type:
- Article
Metformin restores cisplatin cytotoxicity reduced by allantoin in CML in vitro.
- Published in:
- World Academy of Sciences Journal, 2021, p. N.PAG, doi. 10.3892/wasj.2021.116
- By:
- Publication type:
- Article
Performance Assessment of Deep Learning Models on Non-Small Cell Lung Cancer Type Classification.
- Published in:
- EAI Endorsed Transactions on Pervasive Health & Technology, 2024, v. 10, n. 1, p. 1, doi. 10.4108/eetpht.10.6423
- By:
- Publication type:
- Article
Hsa_circ_0006006 is a potential biomarker for prognosis and cisplatin resistance in non-small cell lung cancer.
- Published in:
- Hereditas, 2025, v. 162, n. 1, p. 1, doi. 10.1186/s41065-025-00392-w
- By:
- Publication type:
- Article
Safety and efficacy of pemetrexed for patients with non-small cell lung cancer in the setting of renal impairment: a retrospective study.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13785-x
- By:
- Publication type:
- Article
An Exceptional Case of Garcin Syndrome Mimicking Bell's Palsy in Advanced Non-Small Cell Lung Carcinoma.
- Published in:
- Indian Journal of Otolaryngology & Head & Neck Surgery, 2025, v. 77, n. 2, p. 1062, doi. 10.1007/s12070-024-05258-7
- By:
- Publication type:
- Article
The impact of lung surgery, with or without (neo-)adjuvant therapy, on physical functioning in patients with nonsmall cell lung cancer: a scoping review.
- Published in:
- European Respiratory Review, 2025, v. 34, n. 175, p. 1, doi. 10.1183/16000617.0156-2024
- By:
- Publication type:
- Article
Low-coverage whole genome sequencing of cell-free DNA to predict and track immunotherapy response in advanced non-small cell lung cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2025, v. 44, n. 1, p. 1, doi. 10.1186/s13046-025-03348-0
- By:
- Publication type:
- Article
HNRNPC promotes progression of non-small cell lung cancer by maintaining TFAP2A mRNA stability.
- Published in:
- Cancer Cell International, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12935-025-03660-x
- By:
- Publication type:
- Article
Aniline TFPA enhances camptothecin-induced anti-NSCLC by modulating oxidative stress and impairing autophagy.
- Published in:
- Cancer Cell International, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12935-025-03657-6
- By:
- Publication type:
- Article
Single-cell analysis reveals transcriptomic features and therapeutic targets in primary pulmonary lymphoepithelioma-like carcinoma.
- Published in:
- Communications Biology, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s42003-025-07819-0
- By:
- Publication type:
- Article
Real-World Survival Outcomes in Patients with Different Types of Cancer Managed with Immune Checkpoint Inhibitors.
- Published in:
- Oncology Research & Treatment, 2025, v. 48, n. 3, p. 82, doi. 10.1159/000542958
- By:
- Publication type:
- Article
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2024: Targeted Therapies in Non-Small Cell Lung Cancer.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Real world experience with MET inhibitors in MET exon 14 skipping mutated non-small cell lung cancer: largest Indian perspective.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-01864-1
- By:
- Publication type:
- Article